eConsent: The Missing Ingredient To More Engaging Clinical Trials
Source: IQVIA Technologies
By Vinita Navadgi, Sr. Director, Patient Consent, IQVIA Technologies
Electronic informed consent (eConsent) platforms are among the most advantageous clinical technology products that sponsors and sites can add to their operations. These tools bring value for all stakeholders in the process.
- They simplify complex consent processes for participants, which leads to better engagement,
- They reduce the burden of paperwork for clinical staff, which leads to greater accuracy and efficiency, and
- They provide sponsors with real-time participant consent data to support the study management and regulatory processes.
So why have so many clinical trial sites delayed adoption of eConsent solutions?
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader